These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries. Alserri A; Holzer H; Tulandi T J Obstet Gynaecol Can; 2012 Sep; 34(9):866-869. PubMed ID: 22971456 [TBL] [Abstract][Full Text] [Related]
3. [A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation]. Moosová M; Moos J; Filová V; Pavelková J; Jarosová R; Rezábek K Ceska Gynekol; 2011 Apr; 76(2):123-7. PubMed ID: 21649996 [TBL] [Abstract][Full Text] [Related]
4. A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Wu L; Sun Y; Wan J; Luan T; Cheng Q; Tan Y Mol Med Rep; 2017 Jul; 16(1):272-280. PubMed ID: 28534980 [TBL] [Abstract][Full Text] [Related]
5. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Swanton A; Story L; McVeigh E; Child T Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):68-71. PubMed ID: 20022685 [TBL] [Abstract][Full Text] [Related]
6. Ovarian hyperstimulation syndrome: definition, incidence, and classification. Zivi E; Simon A; Laufer N Semin Reprod Med; 2010 Nov; 28(6):441-7. PubMed ID: 21082501 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries]. Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721 [TBL] [Abstract][Full Text] [Related]
8. Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Peitsidis P; Agrawal R Reprod Biomed Online; 2010 Apr; 20(4):444-52. PubMed ID: 20156703 [TBL] [Abstract][Full Text] [Related]
9. Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome. Ohata Y; Harada T; Ito M; Yoshida S; Iwabe T; Terakawa N Gynecol Obstet Invest; 2000; 50(3):186-8. PubMed ID: 11014952 [TBL] [Abstract][Full Text] [Related]
10. Severe ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy after ovulation induction: a case report. Yang F; Hu H; He PZ; Zhang M; Qian Y; Li Y Clin Exp Obstet Gynecol; 2017; 44(2):292-295. PubMed ID: 29746043 [TBL] [Abstract][Full Text] [Related]
11. Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles. Oyawoye OA; Chander B; Hunter J; Gadir AA MedGenMed; 2005 Aug; 7(3):60. PubMed ID: 16369286 [TBL] [Abstract][Full Text] [Related]
12. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E; Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727 [TBL] [Abstract][Full Text] [Related]
13. Persistent megalocystic ovaries after ovarian hyperstimulation syndrome in a postpartum patient with polycystic ovarian syndrome: a case report. Shi J; Ren X; Tian Q; Sun A; Chen R J Ovarian Res; 2018 Sep; 11(1):79. PubMed ID: 30201001 [TBL] [Abstract][Full Text] [Related]
14. Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Boothroyd C; Karia S; Andreadis N; Rombauts L; Johnson N; Chapman M; Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):523-34. PubMed ID: 26597569 [TBL] [Abstract][Full Text] [Related]
15. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Esinler I; Bayar U; Bozdag G; Yarali H Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846 [TBL] [Abstract][Full Text] [Related]
16. Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Zhao C; Liu X; Shi Z; Zhang J; Zhang J; Jia X; Ling X Cell Physiol Biochem; 2015; 35(3):1086-94. PubMed ID: 25662703 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound evaluation of PCO, PCOS and OHSS. Battaglia C; Mancini F; Persico N; Zaccaria V; de Aloysio D Reprod Biomed Online; 2004 Dec; 9(6):614-9. PubMed ID: 15670405 [TBL] [Abstract][Full Text] [Related]
18. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978 [TBL] [Abstract][Full Text] [Related]
19. Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome. Gurgan T; Demirol A; Guven S; Benkhalifa M; Girgin B; Li TC Fertil Steril; 2011 Jul; 96(1):53-7. PubMed ID: 21621772 [TBL] [Abstract][Full Text] [Related]